Glucagon-like peptide 1 receptor agonists in type 1 diabetes mellitus.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Glucagon-like peptide 1 receptor agonists in type 1 diabetes mellitus.
- Published In:
- American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 76(21), 1739-1748 (2019)
- Authors:
- Guyton, Justinne, Jeon, Michelle, Brooks, Amie
- Database ID:
- RPEP-04212
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04212APA
Guyton, Justinne; Jeon, Michelle; Brooks, Amie. (2019). Glucagon-like peptide 1 receptor agonists in type 1 diabetes mellitus.. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 76(21), 1739-1748. https://doi.org/10.1093/ajhp/zxz179
MLA
Guyton, Justinne, et al. "Glucagon-like peptide 1 receptor agonists in type 1 diabetes mellitus.." American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2019. https://doi.org/10.1093/ajhp/zxz179
RethinkPeptides
RethinkPeptides Research Database. "Glucagon-like peptide 1 receptor agonists in type 1 diabetes..." RPEP-04212. Retrieved from https://rethinkpeptides.com/research/guyton-2019-glucagonlike-peptide-1-receptor
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.